PathMap Literature Based Discovery Engine
Share your Discovery:
Guaranteed to find unpublished literature based discoveries.
Hypothesis: If Botox were injected into the nerve ending on the third toe on the left foot, the toxin can "climb" retrograde from toe through motor neurons eventually to the brain and temporarily inhibit vesicular docking "from toe to head", potentially allowing a timed pharmacological therapeutic window for toxic EV clearance through the lymph system instead of docking and seeding.


Botulinum Toxins, Type A
_gates_from_botulinum_toxins__type_a
Axonal Transport
_gates_to_axonal_transport
_gates_from_axonal_transport
SNARE Proteins
_gates_to_snare_proteins
_gates_from_snare_proteins
Lymphatic Vessel Endothelial Hyaluronan Receptor-1
_gates_to_lymphatic_vessel_endothelial_hyaluronan_receptor_1
SOD1 Research July 2026


ALS; FUS; STMN2; TDP-43; protein translation; stress granule


Sarcopenia and Amyotrophic Lateral Sclerosis: Biological Pathways and Analysis


The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.


Diabetes Mellitus, Type 2
_gates_from_diabetes_mellitus__type_2
Extracellular Vesicles
_gates_to_extracellular_vesicles
_gates_from_extracellular_vesicles
DNA-Binding Proteins
_gates_to_dna_binding_proteins
_gates_from_dna_binding_proteins
Amyotrophic Lateral Sclerosis
_gates_to_amyotrophic_lateral_sclerosis
What kinds of changes in voice occur prior to Amyotrophic Lateral Sclerosis onset?






